VIP and tolerance induction in autoimmunity
Vasoactive intestinal peptide (VIP) is a potent antiinflammatory agent with immunoregulatory properties, skewing the immune response to a Th2 pattern of cytokine production. Here, we studied the effect of treatment with VIP in the development of diabetes in nonobese diabetic (NOD) mice, an annual mo...
Guardado en:
Autores principales: | Rosignoli, F., Torroba, M., Juarranz, Y., García-Gómez, M., Martinez, C., Gomariz, R.P., Pérez-Leirós, C., Leceta, J. |
---|---|
Formato: | SER |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_00778923_v1070_n_p525_Rosignoli |
Aporte de: |
Ejemplares similares
-
VIP and tolerance induction in autoimmunity
por: Rosignoli, Florencia, et al.
Publicado: (2006) -
VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells
por: Fraccaroli, L., et al. -
Disease-modifying immunotherapy for the management of autoimmune diabetes
Publicado: (2010) -
Disease-modifying immunotherapy for the management of autoimmune diabetes
por: Castro, C.N., et al. -
VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells
Publicado: (2009)